Start free trial
Trending New Genres Authors
EnglishEnglish
EspañolSpanish
简体中文Chinese
繁體中文Chinese (Traditional)
FrançaisFrench
DeutschGerman
日本語Japanese
PortuguêsPortuguese
ItalianoItalian
한국어Korean
РусскийRussian
NederlandsDutch
العربيةArabic
PolskiPolish
हिन्दीHindi
Tiếng ViệtVietnamese
SvenskaSwedish
ΕλληνικάGreek
TürkçeTurkish
ไทยThai
ČeštinaCzech
RomânăRomanian
MagyarHungarian
УкраїнськаUkrainian
IndonesiaIndonesian
DanskDanish
SuomiFinnish
БългарскиBulgarian
עבריתHebrew
NorskNorwegian
HrvatskiCroatian
CatalàCatalan
SlovenčinaSlovak
LietuviųLithuanian
SlovenščinaSlovenian
СрпскиSerbian
EestiEstonian
LatviešuLatvian
فارسیPersian
മലയാളംMalayalam
தமிழ்Tamil
اردوUrdu
Searching...
SoBrief
Niacin

Niacin

The Real Story: Learn about the Wonderful Healing Properties of Niacin
Some people may need more B3 than deficiency prevention allows. How strong is the evidence?
by Abram Hoffer 2011 242 pages
4.48
318 ratings
Listen
Immersive
V2.3
Amazon Kindle Audible
Try Full Access for 3 Days
Unlock listening & more!
Continue

Key Takeaways

Remember flour fortification: a nutrient can prevent a public-health catastrophe

A deficiency epidemic changed policy. In the early twentieth century, pellagra caused skin disease, diarrhea, cognitive symptoms, and death. The book credits physician Joseph Goldberger with showing that poor diet, rather than infection, drove the epidemic. It reports roughly three million US cases and about 100,000 deaths during the period it discusses.

Fortification worked at scale. In 1942, the United States required niacinamide in enriched flour. The authors say pellagra fell dramatically within two years, including the psychosis that had filled Southern mental hospitals. This history is the book's strongest example of nutrition changing health beyond the individual patient. It also explains why the authors see niacin as more than a supplement for rare deficiency.

Analysis

The fortification story gives the book a firm historical anchor. It shows that nutrition policy can prevent disease across populations, not just support individual wellness. It also invites a useful distinction: preventing a clear deficiency is not the same as proving that high doses treat many unrelated chronic illnesses. The pellagra episode involved a severe, identifiable nutritional problem and a practical public-health intervention. That makes it compelling evidence for food enrichment, while leaving separate therapeutic claims to be evaluated on their own evidence.

Ask whether illness raises nutrient needs beyond the standard deficiency threshold

Deficiency is not the whole theory. The authors distinguish ordinary niacin deficiency, where intake falls short of basic needs, from a proposed “vitamin B3 dependency,” where a person allegedly needs much more than average because of genetics, prolonged poor nutrition, illness, or stress. This is their explanation for why some patients with psychiatric or physical symptoms might not improve on amounts that prevent pellagra.

Needs vary, they argue. Drawing on Roger Williams's idea of biochemical individuality, the book compares nutrient requirements to other traits that vary across a population. It describes Canadian prisoners of war who survived severe malnutrition and stress but remained unwell after release. Hoffer reported that some improved after taking niacin, which he interpreted as evidence of a lasting increased need.

Analysis

The distinction between deficiency and a higher individual requirement is a useful research question. It pushes against assuming that one dietary benchmark fits every body and every circumstance. But the book often treats clinical improvement as confirmation of dependency, which can be difficult to separate from other changes, expectations, or concurrent care. A plausible biological explanation is not itself a diagnostic test. The idea gains strength when paired with measurable markers, well-designed comparisons, and replication, rather than relying on an appealing label to explain a response.

Repair the dietary pattern, not only the niacin number

The wider diet matters. The book argues that refined grains, excess sugar, and low-fiber foods can contribute to a cluster of modern health problems. It calls this proposed cluster “pandeficiency disease,” meaning a broad pattern of illness attributed to multiple nutrient shortfalls, rather than a single missing vitamin. The suggested response is not niacin alone: it includes nutritious whole foods and attention to other vitamins, minerals, and essential fats.

Cleave's theory shaped Hoffer. Royal Navy surgeon T. L. Cleave linked refined carbohydrates and low-fiber diets with conditions such as constipation, diabetes, and coronary disease. Hoffer said Cleave's work changed his own approach to nutrition. The book recommends reducing sugar and processed foods, while acknowledging that individual allergies, stress, and other factors may also affect symptoms.

Analysis

This is one of the book's more practical instincts: a supplement should not become an alibi for a poor dietary pattern. Food quality, fiber, and excess added sugar are legitimate topics for prevention and clinical research. The caution is that grouping many diagnoses under one nutritional explanation can oversimplify conditions with different causes. A strong dietary pattern may support general health without establishing that each named illness is a deficiency syndrome. The broad claim is most useful as a prompt to investigate diet, not as a replacement for diagnosis.

Follow the NAD pathway, but do not mistake a mechanism for a cure

Niacin feeds cellular chemistry. The book explains that niacin and niacinamide can contribute to NAD, short for nicotinamide adenine dinucleotide, a molecule used in energy metabolism, cell signaling, and DNA repair. The authors describe NAD as participating in hundreds of biochemical reactions, offering a possible reason B3 appears relevant to such varied systems.

Mechanisms suggest questions. The book connects NAD-related processes to nerve protection, immune responses, aging, and responses to stress. It discusses research on Wallerian degeneration, the breakdown of a damaged nerve fiber, and studies of NAD-related pathways in animals. These findings help explain why researchers investigate niacin across different conditions. They do not, by themselves, show that a supplement prevents or treats those conditions in people.

Analysis

The NAD story is scientifically generative because it links a small nutrient to many cellular processes. That breadth can help researchers identify hypotheses and potential targets. It can also mislead: when a molecule participates in hundreds of reactions, almost any disease can be made to sound relevant to it. Mechanistic plausibility is an early rung on the evidence ladder, not the finish line. Human studies must establish whether a particular form, dose, and patient group experience meaningful benefits that outweigh harms.

Treat Hoffer's schizophrenia results as promising evidence, not settled practice

Hoffer challenged psychiatric orthodoxy. In the 1950s, psychiatrist Abram Hoffer and colleague Humphry Osmond tested high-dose B3 in patients diagnosed with schizophrenia. The book reports an early controlled study in which two-year recovery was 75 percent in the niacin group, compared with 35 percent in the placebo group. Hoffer later described treating thousands of patients and believed some needed much more than deficiency-prevention amounts.

A family story makes the case vivid. One account describes a father hiding crushed niacin in a jam sandwich for his hospitalized twelve-year-old son. The boy improved and, according to the account, later became a psychiatrist. Hoffer's proposed “adrenochrome hypothesis” linked schizophrenia to oxidized adrenaline and suggested that niacin might alter this process. The hypothesis remains distinct from proof of a general cure.

Analysis

Hoffer's work matters because it asked whether nutrition could contribute to serious psychiatric symptoms at a time when treatment options were limited. The early controlled results deserve historical attention, and the patient's story shows why families search beyond standard care. Yet dramatic cases can create certainty faster than a field should. The book's own accounts vary in sample sizes and outcomes, and its explanations are not equivalent to broad replication. People with psychosis need qualified clinical care; this material does not justify stopping prescribed treatment or trying high doses without medical supervision.

Measure arthritis progress instead of relying on hopeful impressions

Kaufman made mobility observable. Physician William Kaufman used niacinamide for people with arthritis and tracked joint movement through a “Joint Range Index,” a numerical measure of mobility. He argued that frequent, divided doses worked better than giving the same total amount in fewer doses. One early patient who could barely bend his elbow improved after a week, then stiffened again when Kaufman substituted a placebo.

Recovery took time. The book recounts severely disabled patients who improved over months or years, while emphasizing that damaged or fused joints might not recover. It also cites a 72-person pilot study in which niacinamide was associated with a 29 percent reduction in overall disease severity. These accounts support the value of measuring function over time, but they do not establish a universal treatment protocol.

Analysis

The emphasis on objective function is a methodological strength. A mobility measure can reveal change that a vague report of feeling better might miss, while repeated measurements help distinguish a trend from a good day. The placebo episode is suggestive, though an individual case cannot settle efficacy. The pilot study is more informative but remains small. The wider lesson is to define outcomes before treatment and track them consistently, while keeping expectations realistic about conditions involving irreversible structural damage.

Judge heart protection by events, not cholesterol numbers alone

The cardiovascular story began with a surprise. Hoffer and colleagues noticed that niacin lowered cholesterol, then Mayo Clinic physician William Parsons conducted more systematic studies. The book says niacin can raise HDL, lower LDL and triglycerides, and alter other blood-lipid measures. It also describes the Coronary Drug Project, a large study of men who had already experienced a heart attack. In a long-term follow-up, the niacin group had 11 percent lower mortality than the placebo group.

A better lipid panel is not the whole answer. The book argues that niacin's effects on several lipid measures make it unusually promising. It also criticizes studies combining niacin with other drugs, especially laropiprant. But laboratory changes and outcomes in one group of post-heart-attack men cannot establish benefit for everyone or settle how niacin compares with current care.

Analysis

This chapter contains an important principle for evaluating treatments: a favorable change in a biomarker is not automatically a reduction in illness or death. The long-term Coronary Drug Project result gives the authors a meaningful clinical outcome to discuss, but its population and treatment context matter. The book's criticism of combination-drug trials is a reasonable caution about attribution, not proof that niacin alone is beneficial in every setting. Cardiovascular decisions require outcomes evidence, patient-specific risk, and clinician guidance.

Choose the B3 form carefully and treat high doses as medical care

The forms are not interchangeable. The book distinguishes niacin, which can cause a temporary flush and affect blood lipids, from niacinamide, which usually does not flush and is used in the authors' psychiatric and arthritis accounts. Inositol hexaniacinate is presented as a less-flushing alternative. Sustained-release products are treated cautiously because the book describes reports of liver injury, while also noting that high-dose niacin can affect blood sugar and, rarely, vision.

Safety requires context. The authors reject the government's 35-milligram upper limit as excessively restrictive, but their own chapters describe adverse effects and the need for monitoring. Their high-dose regimens are not appropriate for unsupervised experimentation. The text itself advises working with a physician, particularly for people with liver disease, diabetes, heavy alcohol use, pregnancy, or other medical conditions.

Analysis

The form-specific distinctions are essential because “niacin” can refer to products with different effects and risks. The book is right to warn that formulation matters, especially when it discusses sustained-release products. Its broader reassurance that vitamins are nearly harmless is less careful than its own examples of adverse effects. Safety is dose-dependent and patient-dependent; the absence of a dramatic event in a case series cannot establish safety for everyone. Readers should not use the book's disputed dose claims as instructions or replace established care.

Sort niacin's many disease claims by evidence strength before acting

The book ranges far beyond pellagra. It presents niacin or niacinamide as potentially relevant to arthritis, addiction, fatigue, skin disease, kidney disease, cancer, neurological conditions, and COVID-19. The evidence it offers is mixed in kind: historical fortification, laboratory pathways, animal experiments, observational findings, small trials, physician case reports, and personal stories. These forms of evidence answer different questions and should not be treated as equally conclusive.

The authors make a case for investigation. For example, the COVID-19 chapter discusses NAD depletion and early clinical observations, while the kidney chapter combines phosphate studies with case reports. Those findings may justify further study, but they do not establish niacin as a proven treatment for these illnesses. The book's most durable invitation is to ask what works, then demand evidence proportionate to the claim.

Analysis

The breadth of the book is both its organizing idea and its greatest risk. A common molecule can connect multiple pathways, but a long list of possible uses can blur the difference between established deficiency treatment and tentative therapeutic proposals. A reader can preserve the authors' curiosity while applying a simple hierarchy: human outcome trials generally answer clinical questions better than animal models, mechanisms, or anecdotes. That standard neither dismisses unconventional hypotheses nor grants them a free pass. It gives promising ideas a clear route toward reliable care.

Analysis

Niacin: The Real Story is part medical history, part clinical memoir, and part polemic for orthomolecular medicine. Its narrative begins with pellagra and the public-health success of flour enrichment, then follows Abram Hoffer's turn from psychiatric practice toward high-dose nutrient therapy. William Kaufman's arthritis observations and William Parsons's lipid studies widen the case, while later contributors connect niacin to NAD biology and a long list of diseases. The book's central proposal is that some people need far more B3 than basic deficiency-prevention standards provide, particularly under genetic, nutritional, or physiological stress.

The strongest material is historical and specific: fortification against pellagra, early controlled psychiatric studies, Kaufman's attempts to measure joint mobility, and the Coronary Drug Project's long-term follow-up. The weaker move is treating these unlike forms of evidence as one continuous proof. Mechanistic research, case reports, small trials, and large outcome studies cannot carry equal weight. Nor does evidence that niacin changes HDL, NAD, or inflammation establish that it prevents or cures every disease associated with those systems. The authors are also right to ask why cheap, nonpatentable interventions may receive less commercial attention. But financial incentives can explain research gaps without proving that an intervention works or that evidence has been suppressed. The book sometimes overstates safety and presents contested interpretations as settled conclusions. Its own discussion of formulation-related liver injury, nausea, glucose changes, and rare eye effects shows why blanket assurances are unwise.

The most useful reading is therefore neither credulous nor dismissive. Treat the pellagra history as a strong public-health lesson, the clinical reports as hypotheses worth evaluating, and the broad disease claims as proposals rather than instructions. High-dose niacin is not a substitute for diagnosis or professional care. The book's lasting contribution is to insist that nutritional questions belong in medicine, while its claims still need the same disciplined testing expected of any treatment.

Summary in 30 Seconds
US flour fortification with niacinamide began in 1942, and pellagra fell sharply within two years after causing roughly three million cases and 100,000 deaths. Hoffer's early schizophrenia study reported two-year recovery in 75 percent of the niacin group versus 35 percent on placebo; a heart study follow-up found 11 percent lower mortality. Such findings do not prove broad benefits. B3 forms differ, and high doses can harm the liver, blood sugar, or vision, so medical supervision matters.
Contains spoilers

Last updated:

Report Issue

Review Summary

4.48 out of 5
Average of 318 ratings from Goodreads and Amazon.

Niacin by Abram Hoffer receives high praise from readers for its comprehensive information on the health benefits of niacin. Many report personal success using niacin for various conditions, including mental health issues, cholesterol, and arthritis. Readers appreciate the scientific evidence presented and the potential of niacin as an alternative to pharmaceutical drugs. Some find the book technical but informative. Critics note organizational issues and repetitiveness. Overall, reviewers consider it an essential read for those interested in orthomolecular medicine and natural health approaches.

Your rating:
4.68
266 ratings
Want to read the full book?

Glossary

Orthomolecular medicine

Nutrient-based treatment approach

A medical approach, named by Linus Pauling, that aims to prevent or treat illness by adjusting concentrations of substances normally present in the body, especially nutrients. In this book, it means using food and individualized vitamin or mineral supplementation as central parts of care, rather than relying only on pharmaceutical drugs.

Vitamin B3 dependency

Higher-than-average B3 requirement

The authors' term for a proposed state in which a person requires substantially more vitamin B3 than ordinary dietary or deficiency-prevention amounts. They associate this increased need with factors such as genetic variation, prolonged malnutrition, illness, or stress. The book uses the concept to explain why some patients may not respond to small doses.

Pandeficiency disease

Proposed multiple-nutrient shortfall

The book's label for a broad pattern of illness that the authors attribute to deficiencies in several nutrients, rather than a single vitamin. They associate it with modern diets high in refined carbohydrates and low in nutrient-rich whole foods, and describe a response involving dietary improvement and several nutrients. It is an advocacy concept, not a standard diagnostic category.

Adrenochrome hypothesis

Proposed biochemical account of psychosis

Hoffer and colleagues' hypothesis that excessive oxidation of adrenaline produces adrenochrome, a compound they believed could contribute to perceptual changes and psychosis. They proposed that niacin might influence the relevant biochemical processes. The book presents this as an explanation for some psychiatric symptoms, but the hypothesis is not equivalent to an established cause or proven treatment mechanism.

Joint Range Index

Numerical joint-mobility measure

William Kaufman's measure for tracking joint movement in people treated for arthritis. He assigned numerical values to ranges of motion and used changes over repeated examinations to assess improvement. The index provided a way to track function more systematically than relying only on a patient's general impression, although the treatment claims around it require broader confirmation.

Coronary Drug Project

Post-heart-attack drug study

A large US clinical study that compared niacin and other treatments with placebo in men who had previously experienced a heart attack. The book highlights a later follow-up reporting lower mortality in the niacin group. Its findings are relevant to that study population and period, not automatic proof of benefit for every patient or current treatment setting.

Niacin flush

Temporary skin-warming reaction

A temporary redness, warmth, or tingling of the skin that can follow niacin, especially when someone begins taking it or increases the amount. The book attributes it to widening of small blood vessels and discusses how meal timing, dose, and formulation affect it. The authors often frame it as a tolerability issue, but it does not by itself establish benefit or safety.

FAQ

What's Niacin: The Real Story about?

  • Focus on Niacin's Benefits: The book delves into the therapeutic properties of niacin (vitamin B3) and its effectiveness in treating various health conditions, including mental illnesses and cardiovascular diseases.
  • Historical Context: It provides a historical perspective on niacin's role in medicine, highlighting Dr. Abram Hoffer's pioneering work in using niacin to treat schizophrenia.
  • Orthomolecular Medicine: The authors advocate for orthomolecular medicine, which emphasizes using nutrients in optimal amounts to prevent and treat diseases, contrasting with conventional drug-based approaches.

Why should I read Niacin: The Real Story?

  • Evidence-Based Insights: The book offers compelling evidence and case studies supporting niacin's use for various health issues, making it a valuable resource for patients and healthcare providers.
  • Cost-Effective Treatment: Niacin is inexpensive and has minimal side effects compared to many pharmaceuticals, appealing to those seeking alternative treatments.
  • Empowerment Through Knowledge: Readers will gain a deeper understanding of how nutritional deficiencies can lead to health problems and how niacin can be a key part of a holistic treatment plan.

What are the key takeaways of Niacin: The Real Story?

  • Niacin's Versatility: The book emphasizes niacin's effectiveness in treating a wide range of conditions, including mental health disorders, cardiovascular issues, and some cancers.
  • Importance of Dosage: It highlights the necessity of using adequate doses of niacin for therapeutic effects, often much higher than the Recommended Dietary Allowance (RDA).
  • Nutritional Deficiency Awareness: The authors stress recognizing nutritional deficiencies as a root cause of many health issues, advocating for a shift towards nutrition-based medicine.

What are the best quotes from Niacin: The Real Story and what do they mean?

  • “The physician must know niacin in order to use it.”: This underscores the importance of understanding niacin's effects and applications in medical practice, suggesting many healthcare providers lack this knowledge.
  • “For schizophrenics, the natural recovery rate is 50 percent. With orthomolecular medicine, the recovery rate is 80 percent.”: This highlights niacin therapy's potential effectiveness compared to traditional treatments, emphasizing its role in improving patient outcomes.
  • “The number-one side effect of vitamins is failure to take enough of them.”: This statement points to the common misconception that vitamins are unnecessary, advocating for higher dosages to achieve health benefits.

How does niacin work in the body according to Niacin: The Real Story?

  • Biochemical Role: Niacin is a precursor to NAD (nicotinamide adenine dinucleotide), essential for over 500 biochemical reactions, including energy production and DNA repair.
  • Vasodilation Effect: It activates prostaglandin pathways, leading to vasodilation, which can improve blood flow and reduce cholesterol levels.
  • Mental Health Impact: The book discusses how niacin can help alleviate symptoms of mental illnesses by reducing oxidative stress and inflammation in the brain.

What are the different forms of niacin and how do they differ?

  • Niacin vs. Niacinamide: Niacin (nicotinic acid) causes flushing and has lipid-lowering effects, while niacinamide does not cause flushing and is often used for its anti-inflammatory properties.
  • Inositol Hexaniacinate: Marketed as "no-flush" niacin, it is less effective for cholesterol management but can still provide some benefits for mental health.
  • Dosage Considerations: The book emphasizes that niacin's effectiveness varies by form and dosage, with higher doses often required for therapeutic effects.

What conditions can niacin help treat according to Niacin: The Real Story?

  • Mental Illness: The book details niacin's effectiveness in treating schizophrenia, bipolar disorder, and other psychiatric conditions, often with higher recovery rates than traditional medications.
  • Cardiovascular Disease: Niacin improves lipid profiles by lowering LDL cholesterol and raising HDL cholesterol, making it valuable in preventing heart disease.
  • Other Health Issues: Conditions such as arthritis, anxiety, and certain cancers are discussed, with evidence supporting niacin's role in their management.

How should I take niacin for optimal results according to Niacin: The Real Story?

  • Dosage Guidelines: The authors recommend starting with lower doses and gradually increasing to therapeutic levels, often suggesting 3,000 mg per day divided into multiple doses.
  • Timing and Frequency: Taking niacin with meals can improve absorption and reduce flushing, and it should be taken consistently for the best results.
  • Monitoring Effects: Patients should work with their healthcare provider to monitor their response to niacin, adjusting dosages as necessary based on individual needs and side effects.

What are the safety concerns associated with niacin according to Niacin: The Real Story?

  • Liver Health: While some believe niacin can cause liver damage, the book argues that elevated liver enzymes often indicate liver activity rather than pathology, especially at therapeutic doses.
  • Flushing Reaction: The flushing effect is a common side effect of niacin, which can be managed by starting with lower doses and gradually increasing them.
  • Overall Safety Record: Niacin has a long history of safe use, with no reported deaths from niacin overdose, making it a low-risk option for many patients.

How does niacin compare to pharmaceutical treatments according to Niacin: The Real Story?

  • Cost-Effectiveness: Niacin is significantly cheaper than many prescription medications, making it accessible for a broader range of patients.
  • Fewer Side Effects: Unlike many pharmaceuticals, niacin has minimal side effects, primarily flushing, which is generally well-tolerated and reversible.
  • Efficacy: The book presents evidence that niacin can be more effective than many drugs for certain conditions, particularly in mental health and cardiovascular health, challenging the dominance of pharmaceutical treatments.

What is the relationship between niacin and mental health according to Niacin: The Real Story?

  • Schizophrenia Treatment: Niacin has been used successfully to treat schizophrenia, with many patients experiencing significant improvements in symptoms when given high doses.
  • Anxiety and Depression: The book discusses niacin's calming effects, which can help alleviate anxiety and depressive symptoms, making it a valuable tool in mental health treatment.
  • Nutritional Deficiency: Hoffer posits that many mental health disorders may stem from nutritional deficiencies, particularly in niacin, and that addressing these deficiencies can lead to recovery.

How does Niacin: The Real Story define niacin dependency?

  • Definition of Dependency: Niacin dependency occurs when individuals require higher doses of niacin than the standard recommended dietary allowance (RDA) due to genetic or metabolic factors.
  • Clinical Evidence: The book presents clinical cases where patients with mental illnesses showed significant improvement when treated with high doses of niacin, suggesting a biochemical need for the vitamin.
  • Implications for Treatment: Understanding niacin dependency is crucial for developing effective treatment plans for individuals with psychiatric disorders, as it highlights the need for personalized nutrition strategies.

About the Author

Abram Hoffer M.D. Ph.D. was a pioneering figure in orthomolecular medicine, advocating for the use of vitamins and nutrients in treating mental illnesses. He gained recognition for his work on megavitamin therapy, particularly using high doses of niacin to treat schizophrenia and alcoholism. Hoffer's approach challenged conventional psychiatric treatments, emphasizing nutritional deficiencies as a root cause of mental health issues. His research and clinical experience spanned several decades, during which he published numerous books and papers on the subject. Despite facing skepticism from the mainstream medical community, Hoffer's work has influenced alternative and integrative medicine approaches to mental health treatment.

Download PDF

To save this Niacin summary for later, download the free PDF. You can print it out, or read offline at your convenience.
Download PDF
File size: 0.41 MB     Pages: 19

Download EPUB

To read this Niacin summary on your e-reader device or app, download the free EPUB. The .epub digital book format is ideal for reading ebooks on phones, tablets, and e-readers.
Download EPUB
File size: 1.40 MB     Pages: 25
Want to read the full book?
Follow
Listen
Home
Swipe
Library
Get App
Try Full Access for 3 Days
Listen, bookmark, and more
Compare Features Free Pro
📖 Read Summaries
Read unlimited summaries. Free users get 3 per month
🎧 Listen to Summaries
Listen to unlimited summaries in 40 languages
—
❤️ Unlimited Bookmarks
Free users are limited to 4
—
📜 Unlimited History
Free users are limited to 4
—
📥 Unlimited Downloads
Free users are limited to 1
—
Risk-Free Timeline
Today: Get Instant Access
Listen to full summaries of 26,000+ books. That's 12,000+ hours of audio!
Day 2: Trial Reminder
We'll send you a notification that your trial is ending soon.
Day 3: Your subscription begins
You'll be charged on Nov 24,
cancel anytime before.
Consume 2.8× More Books
2.8× more books Listening Reading
Our users love us
1M+ readers
Trustpilot Rating
TrustPilot
4.6 Excellent
This site is a total game-changer. I've been flying through book summaries like never before. Highly, highly recommend.
— Dave G
Worth my money and time, and really well made. I've never seen this quality of summaries on other websites. Very helpful!
— Em
Highly recommended!! Fantastic service. Perfect for those that want a little more than a teaser but not all the intricate details of a full audio book.
— Greg M
Save 62%
Yearly
$119.88 $44.99/year/yr
$3.75/mo
Monthly
$9.99/mo
Start a 3-Day Free Trial
3 days free, then $44.99/year. Cancel anytime.
Unlock a world of fiction & nonfiction books
26,000+ books for the price of 2 books
Read any book in 10 minutes
Discover new books like Tinder
Request any book if it's not summarized
Read more books than anyone you know
#1 app for book lovers
Lifelike & immersive summaries
30-day money-back guarantee
Download summaries in EPUBs or PDFs
Cancel anytime in a few clicks

Why one summary?

Scanner
Find a barcode to scan

⭐
⭐
⭐
We have a special gift for you
Open
38% off
DISCOUNT FOR YOU
⭐
⭐
⭐
$79.99
$49.99/year
Only $4.16 per month
Continue
2 taps to start, super easy to cancel
Settings
General
Widget
Loading...